when were glp-1 agonists approved for weight loss GLP-1R Frontiers | GLP−1 receptor agonists
Description
Looking at the global market, GLP-1RA has steadily increased its share in the market of hypoglycemic drugs
The FDA includes all the GLP-1s from above in the same medicine classification and is evaluating reports of suicidal thoughts or actions in people taking GLP-1s
Research protocols that begin at the target dose without escalation may produce confounding adverse effect data
The mechanism parallels the early worsening seen in the DCCT and UKPDS studies after intensive glucose reduction
